Fidelity International
LSB

Fidelity International’s LakeShore Biopharma LSB Stock Holding History

Fidelity International’s Portfolio LSB Stock Details LSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-61,548
Closed -$424K – 993
2024
Q3 		$424K Sell
61,548
-11,794
-16% -$61.1K ﹤0.01% 789
2024
Q2 		$475K Sell
73,342
-47,134
-39% -$385K ﹤0.01% 757
2024
Q1 		$843K Sell
120,476
-99,757
-45% -$508K ﹤0.01% 729
2023
Q4 		$1.18M Sell
220,233
-50,334
-19% -$290K ﹤0.01% 696
2023
Q3 		$2.16M Sell
270,567
-1,283
-0.5% -$14.8K ﹤0.01% 629
2023
Q2 		$3.75M Hold
271,850
– – ﹤0.01% 591
2023
Q1 		$4.35M Buy
+271,850
New +$13.8M 0.01% 581

Other funds holding LSB

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return